scispace - formally typeset
G

Gi Ming Lai

Researcher at Taipei Medical University

Publications -  36
Citations -  1478

Gi Ming Lai is an academic researcher from Taipei Medical University. The author has contributed to research in topics: Apoptosis & Cancer cell. The author has an hindex of 18, co-authored 34 publications receiving 1325 citations. Previous affiliations of Gi Ming Lai include National Health Research Institutes & Memorial Hospital of South Bend.

Papers
More filters
Journal ArticleDOI

Basal levels and patterns of anticancer drug-induced activation of nuclear factor-κB (NF-κB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells☆

TL;DR: It is demonstrated that activation of NF-kappaB is a general cellular response to anticancer drugs, and the mechanism of activation appears to be distinct from that induced by TNF-alpha.
Journal ArticleDOI

Cytotoxic triterpenes from Antrodia camphorata and their mode of action in HT-29 human colon cancer cells

TL;DR: Five lanostane (2, 3, 4, 6 and 8) and three ergostane-type triterpenes isolated from the fruiting bodies of Antrodia camphorata were evaluated for their in vitro cytotoxic data against various cancer cell types.
Journal ArticleDOI

Sulfasalazine Suppresses Drug Resistance and Invasiveness of Lung Adenocarcinoma Cells Expressing AXL

TL;DR: Sulfasalazine exerted a synergistic anticancer effect with doxorubicin and suppressed cancer cell invasiveness in parallel in CL1 sublines and various AXL-expressing cancer cell lines, suggesting that AXL is involved in NSCLC metastasis and drug resistance and may therefore provide a molecular basis for RTK-targeted therapy using sulfasalazines to enhance the efficacy of chemotherapy inNSCLC.
Journal ArticleDOI

Identification and characterization of a novel gene Saf transcribed from the opposite strand of Fas

TL;DR: It is suggested that Saf might protect T lymphocytes from Fas-mediated apoptosis by blocking the binding of FasL or its agonistic Fas antibody, and might regulate the expression of Fas alternative splice forms through pre-mRNA processing.